Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06094478 · ClinicalTrials.gov registry record · NA

Hospital Implementation of a Stroke Protocol for Emergency Evaluation and Disposition

A NA study of Stroke, Acute and Hemorrhagic Stroke, sponsored by University of Chicago.

Recruiting
Registry status
NA
Development phase
900
Enrollment target
7
Study locations

NCT06094478: Recruiting NA study of Stroke, Acute and Hemorrhagic Stroke, sponsored by University of Chicago.

NCT06094478 is a NA study of Stroke, Acute and Hemorrhagic Stroke that is actively recruiting participants, run by University of Chicago. The registered enrollment target is 900 participants, above the 594-participant average among 25 other Stroke, Acute trials with a reported enrollment target (52% higher). The trial reports 7 study locations across 7 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06094478, a NA study of Stroke, Acute and Hemorrhagic Stroke, is actively recruiting participants, sponsored by University of Chicago.

RECRUITING
Registry status
NA
Development phase
900 participants
Enrollment target
7
Study locations

Study Summary

Most stroke patients are initially evaluated at the closest hospital but some need to be transferred to a hospital that can provide more advanced care. The "Door-In-Door-Out" (DIDO) process at the first hospital can take time making transferred patients no longer able to get the advanced treatments. This study will help hospitals across the US "stand up" new ways to evaluate stroke patients, decide who needs to be transferred, and transfer them quickly for advanced treatment.

Primary Outcome

Time from ED arrival to ED departure prior to transfer to a comprehensive stroke center among ischemic stroke patients

Interventions

  • BEHAVIORAL HI-SPEED Protocol

Study Locations (7)

Connecticut

  • Yale New Haven Hospital - New Haven

Florida

  • Jackson Memorial Hospital - Miami

Georgia

  • Emory University Hospital - Atlanta

Illinois

  • UChicago Medicine Ingalls Memorial Hospital - Chicago

New York

  • New York Presbyterian - Weill Cornell Hospital - New York

Ohio

  • University of Cincinnati Medical Center - Cincinnati

Utah

  • University of Utah Health - Salt Lake City

Trial Details

FieldValue
Enrollment Target 900 participants
Start Date 2024-10-17
Est. Completion 2028-07-31
Phase NA
University of Chicago

796 total trials

What NCT06094478 shows while recruiting

NCT06094478 is an interventional study that assigns participants to a tested intervention. The registered 900 participants enrollment target is mid-sized for trials with a published cap, above the 594-participant average among 25 other Stroke, Acute trials with a reported enrollment target (52% higher).

The record links to 3 conditions, with Stroke, Acute appearing as the primary indexed condition, and to 1 intervention - of which HI-SPEED Protocol is the first listed.

NCT06094478 lists 7 locations in 7 states (Connecticut, Florida, Georgia).

Frequently Asked Questions

What is clinical trial NCT06094478 about?

NCT06094478 is a clinical study titled "Hospital Implementation of a Stroke Protocol for Emergency Evaluation and Disposition". Most stroke patients are initially evaluated at the closest hospital but some need to be transferred to a hospital that can provide more advanced care. The "Door-In-Door-Out" (DIDO) process at the first hospital can take time making transferred patients no longer able to get the advanced treatments....

What is the current status of trial NCT06094478?

This trial is currently recruiting. It is a NA study. The enrollment target is 900 participants. The study started on 2024-10-17. Estimated completion is 2028-07-31.

What conditions does trial NCT06094478 study?

This clinical trial studies the following conditions: Stroke, Acute, Hemorrhagic Stroke, Ischemic Stroke, Acute.

What interventions are being tested in trial NCT06094478?

The interventions under investigation include: HI-SPEED Protocol (BEHAVIORAL).

Who is sponsoring clinical trial NCT06094478?

This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06094478 being conducted?

This trial has 7 study locations across Connecticut, Florida, Georgia, Illinois, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Stroke, Acute

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06094478's enrollment target sits among peer trials

900 5th of 25 higher than 21 of 25 other Stroke, Acute trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Stroke, Acute trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02352116 · 900 participants · NA

    Evaluation of Post-PACU Pain Management in Pediatric Surgery

  • NCT02414347 · 900 participants

    F 18 T807 Tau PET Imaging of Alzheimer's Disease

  • NCT02670408 · 900 participants

    Diagnostic and Therapeutic Applications of Microarrays in Heart Transplantation

  • NCT02960022 · 900 participants · Phase 2

    A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06094478, the US trial registry maintained by the National Library of Medicine. NCT06094478 (mid enrollment · multi site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.